An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females

<strong>Background</strong> There are known differences in vaccine reactogenicity and immunogenicity by sex. Females have been shown to report greater reactogenicity and generate higher humoral and cellular immune responses than males following vaccination with several different vaccines...

Full description

Bibliographic Details
Main Authors:	Marchevsky, NG, Li, G, Aley, P, Costa Clemens, SA, Barrett, JR, Belij-Rammerstorfer, S, Bibi, S, Clutterbuck, E, Dold, C, Felle, S, Flaxman, A, Folegatti, P, Jenkin, D, Gilbert, S, Kelly, S, Lambe, T, Plested, E, Ramasamy, M, Singh, N, Smith, H, Taylor, S, Weckx, L, Pollard, AJ, Voysey, M
Other Authors:	Oxford COVID Vaccine Trial Group
Format:	Journal article
Language:	English
Published:	Elsevier 2022

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females

Similar Items